Neprilysin functional genetic polymorphism in NSCLC progression without PD-L1 expression
M. Pereira Catarata (Coimbra, Portugal), R. Ribeiro (Coimbra, Portugal), M. Oliveira (Porto, Portugal), M. Thomas (Heidelberg, Portugal), M. Meister (Heidelberg, Portugal), T. Muley (Heidelberg, Portugal)
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Session: Biological mechanisms of lung cancer
Session type: E-poster session
Number: 1768
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Pereira Catarata (Coimbra, Portugal), R. Ribeiro (Coimbra, Portugal), M. Oliveira (Porto, Portugal), M. Thomas (Heidelberg, Portugal), M. Meister (Heidelberg, Portugal), T. Muley (Heidelberg, Portugal). Neprilysin functional genetic polymorphism in NSCLC progression without PD-L1 expression. 1768
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Association of polymorphism of the human nm23-H1 gene (NME1) with susceptibility to and severity of non-small cell lung cancer Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007
Polymorphism in GSTM1, GSTT1, p53 and CCR5 genes and lung cancer progression: relation to p53 and Ki-67 protein expression in tumors of non-small cell lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006
Expression status of PD-L1 in NSCLC correlates with disease extension Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018
The association of MMP-7 and MMP-13 genetic polymorphisms with susceptibility to non-small cell lung cancer in Taiwan Source: Annual Congress 2008 - Biology in thoracic tumours Year: 2008
Arg72Pro P53 gene polymorphism as a predisposing factor for non-small cell lung cancer (NSCLC) development Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004
Functional polymorphism of p53 and CCR5 genes in lung carcinoma and bronchail asthma Source: Eur Respir J 2005; 26: Suppl. 49, 591s Year: 2005
Arg72Pro P53 gene polymorphism is associated with P53 mutations in non-small cell lung cancer (NSCLC) patients Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004
Polymorphisms in the interleukin-10 gene promoter are associated with susceptibility to non-small cell lung cancer (NSCLC) Source: Eur Respir J 2005; 26: Suppl. 49, 458s Year: 2005
Investigation of a relationship between NF-KB1A gene polymorphism and non small cell lung cancer (NSCLC) Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
Association of -93G®A polymorphism in the hMLH1 gene with susceptibility to and prognosis of non-small cell lung cancer in Taiwan Source: Eur Respir J 2006; 28: Suppl. 50, 151s Year: 2006
VEGF gene polymorphisms are associated with post-natal lung function development Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011
Contribution of genetic polymorphism of stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, to the susceptibility and severity of non-small cell lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Combined effect of p53 and XRCC1 gene polymorphisms on age-associated lung cancer risk Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics Year: 2008
Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC) Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
Association of polymorphisms in the genes of the urokinase plasminogen activation system with susceptibility to and severity of nonsmall cell lung cancer Source: Annual Congress 2009 - Lung cancer biology Year: 2009
Genotyping single-nucleotide polymorphisms (SNP) in ERCC1, XPD, XRCC1, XRCC3 and MDR-1 and CCND-1 genes for response and toxicity prediction in chemotherapy of non small cell lung cancer (NSCLC) Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007
Analysis of XPD gene Lys751Gln polymorphism as predisposing factor for non-small cell lung cancer (NSCLC) development Source: Eur Respir J 2007; 30: Suppl. 51, 131s Year: 2007
Evaluation of EGFR mutations and ERCC2 polymorphisms in treatment of non-small cell lung cancer Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005
The expression and biological significance of PD-L1 on lung cancer cell lines Source: Annual Congress 2009 - Lung cancer biology Year: 2009
Tissue inhibitors of metalloproteinase-2 C-303T and G-418C genetic polymorphisms are associated with an increased risk of non-small cell lung cancer in Taiwan Source: Annual Congress 2008 - Biology in thoracic tumours Year: 2008